tiprankstipranks
Top Stocks
U.S. Stock Market OverviewTop Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
Top ETFs by AUMSPY ETFQQQ ETF
Stock Comparison
Energy StocksOil StocksBest Value StocksAirline StocksElectric Vehicle StocksMATANA Stocks
New
Bank StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
Global Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsTools for Trading PlatformsData for Hedge FundsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Top ETFs by AUM
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
U.S. Markets
Market Movers
Expert Center
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
Top ETFs by AUM
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Energy Stocks
EV Stocks
Crypto News
Dividend Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

CFRX Stock Latest News

ContraFect announces database lock, interim results from DISRUPT study
The FlyContraFect announces database lock, interim results from DISRUPT study
2M ago
CFRX
ContraFect Provides Update from the Futility Analysis of the Phase 3 DISRUPT Study of Exebacase
Press ReleasesContraFect Provides Update from the Futility Analysis of the Phase 3 DISRUPT Study of Exebacase
2M ago
CFRX
ContraFect announces pricing of $7M registered directoffering
The FlyContraFect announces pricing of $7M registered directoffering
2M ago
CFRX
ContraFect Announces Pricing of $7.0 Million Registered Direct Offering and Concurrent Private Placement
Press ReleasesContraFect Announces Pricing of $7.0 Million Registered Direct Offering and Concurrent Private Placement
2M ago
CFRX
ContraFect announces ANSM approval of CTA for exebacase
The FlyContraFect announces ANSM approval of CTA for exebacase
2M ago
CFRX
ContraFect Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Press ReleasesContraFect Reports Third Quarter 2022 Financial Results and Provides Corporate Update
3M ago
CFRX
ContraFect Announces Presentation of New Clinical Data From a Study Using Exebacase in the LysinDAIR Procedure on Patients With Chronic Knee Prosthetic Joint Infection
Press ReleasesContraFect Announces Presentation of New Clinical Data From a Study Using Exebacase in the LysinDAIR Procedure on Patients With Chronic Knee Prosthetic Joint Infection
5M ago
CFRX
ContraFect Announces Multiple Publications Highlighting the Potential Utility of Lysins for the Treatment of Bone and Joint Infections
Press ReleasesContraFect Announces Multiple Publications Highlighting the Potential Utility of Lysins for the Treatment of Bone and Joint Infections
5M ago
CFRX
ContraFect Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Press ReleasesContraFect Reports Second Quarter 2022 Financial Results and Provides Corporate Update
6M ago
CFRX
ContraFect Announces Publication on Exebacase and CF-296 Demonstrating Potent In Vivo Antimicrobial Activity in Implant-Associated MRSA Osteomyelitis
Press ReleasesContraFect Announces Publication on Exebacase and CF-296 Demonstrating Potent In Vivo Antimicrobial Activity in Implant-Associated MRSA Osteomyelitis
6M ago
CFRX
Presentations at ASM Microbe Conference Demonstrate Potential of ContraFect’s Direct Lytic Agents (DLAs) to Address MRSA Infections
Press ReleasesPresentations at ASM Microbe Conference Demonstrate Potential of ContraFect’s Direct Lytic Agents (DLAs) to Address MRSA Infections
8M ago
CFRX
2 “Strong Buy” Penny Stocks With Massive Upside Potential
Stock Analysis & Ideas2 “Strong Buy” Penny Stocks With Massive Upside Potential
2y ago
CFRX
2 “Strong Buy” Small-Cap Stocks That Could See Outsized Gains
Stock Analysis & Ideas2 “Strong Buy” Small-Cap Stocks That Could See Outsized Gains
3y ago
CFRX